What 10x Genomics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 28 | 50 |
| Total trades | 30 | 63 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 63 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Suliman Shehnaaz | Director | Sep 22 | Open-market sale · S | −1,222 | $82.28 | −$101K | 23,792 |
| Suliman Shehnaaz | Director | Sep 22 | Open-market sale · S | −2,270 | $81.67 | −$185K | 25,014 |
| Suliman Shehnaaz | Director | Sep 22 | Open-market sale · S | −1,325 | $80.82 | −$107K | 27,284 |
| Suliman Shehnaaz | Director | Sep 22 | Open-market sale · S | −614 | $79.51 | −$48.8K | 28,609 |
| Suliman Shehnaaz | Director | Sep 22 | Open-market sale · S | −292 | $78.20 | −$22.8K | 29,223 |
| Saxonov Serge | Chief Executive Officer | Sep 22 | Open-market sale · S | −2,800 | $82.37 | −$231K | 1,050,249 |
| Saxonov Serge | Chief Executive Officer | Sep 22 | Open-market sale · S | −9,900 | $81.83 | −$810K | 1,053,049 |
| Saxonov Serge | Chief Executive Officer | Sep 22 | Open-market sale · S | −9,300 | $80.90 | −$752K | 1,062,949 |
| Saxonov Serge | Chief Executive Officer | Sep 22 | Open-market sale · S | −2,000 | $79.62 | −$159K | 1,072,249 |
| Saxonov Serge | Chief Executive Officer | Sep 22 | Open-market sale · S | −1,000 | $78.23 | −$78.2K | 1,074,249 |
| Taich Adam | Chief Financial Officer | Sep 09 | Open-market sale · S | −13,754 | $65.26 | −$898K | 316,344 |
| Taich Adam | Chief Financial Officer | Sep 09 | Open-market sale · S | −31,428 | $64.31 | −$2.02M | 330,098 |
| Taich Adam | Chief Financial Officer | Sep 09 | Open-market sale · S | −1,206 | $63.68 | −$76.8K | 361,526 |
| Stuelpnagel John R | Director | Sep 03 | Open-market sale · S | −6,174 | $62.61 | −$387K | 328,436 |
| Stuelpnagel John R | Director | Sep 03 | Open-market sale · S | −6,814 | $62.11 | −$423K | 334,610 |
| Stuelpnagel John R | Director | Sep 03 | Open-market sale · S | −7,012 | $60.66 | −$425K | 341,424 |
| Saxonov Serge | Chief Executive Officer | Sep 01 | Gift · G | −100 | — | — | 1,075,249 |
| Saxonov Serge | Chief Executive Officer | Aug 26 | Open-market sale · S | −492 | $64.75 | −$31.9K | 1,075,349 |
| Saxonov Serge | Chief Executive Officer | Aug 26 | Open-market sale · S | −6,494 | $63.98 | −$415K | 1,075,841 |
| Saxonov Serge | Chief Executive Officer | Aug 26 | Open-market sale · S | −3,500 | $63.02 | −$221K | 1,082,335 |
Loading...